Precision Optics Corporation, Inc. (POCI) Stock Price & Analysis
Precision Optics Corporation, Inc. (POCI) rose 1.07% to USD 5.68 as of June 10, 2026 at 10:07 UTC, according to Nexqual real-time market data.
POCI last closed at USD 5.62; the session ranged USD 5.54–5.83 on volume of 19,766 shares. Market capitalization is $62.17M, with a 52-week range of USD 3.55–6.04 (NCM). Source: Nexqual, June 10, 2026 at 10:07 UTC.
Key Statistics (as of June 10, 2026 at 10:07 UTC)
| Price | USD 5.68 |
|---|---|
| Change | ▲ 1.07% (up) |
| Previous Close | USD 5.62 |
| Open | USD 5.59 |
| Day Range | USD 5.54 – 5.83 |
| 52-Week Range | USD 3.55 – 6.04 |
| Volume | 19,766 shares |
| Market Cap | $62.17M |
| Exchange | NCM |
Technical Analysis (POCI)
Nexqual's technical model rates POCI "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 10:07 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 66.36 (neutral) |
| vs SMA50 | Above (USD 4.63) |
| MACD | 0.31 (positive) |
Analyst Ratings (POCI)
Wall Street analysts rate POCI "None" based on 1 analysts, with a mean price target of USD 8 (range USD 8–8), per Nexqual as of June 10, 2026 at 10:07 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 8 |
| High Target | USD 8 |
| Low Target | USD 8 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (POCI)
| Next Earnings Date | 2026-05-13 |
|---|---|
| EPS Estimate | USD -0.06 |
| Revenue Estimate | $7.15M |
Source: Nexqual, June 10, 2026 at 10:07 UTC.
Financials & Fundamentals (POCI)
| Total Revenue | $28.94M |
|---|---|
| Revenue Growth (YoY) | +108.00% |
| Gross Margin | +13.85% |
| Operating Margin | -0.74% |
| Profit Margin | -17.03% |
| ROE | -29.62% |
| Debt / Equity | 21.29 |
| Current Ratio | 2.1 |
| Total Cash | $10.68M |
| Total Debt | $4.28M |
| Free Cash Flow | $28,147 |
Source: Nexqual, June 10, 2026 at 10:07 UTC.
Financial Health Score (POCI)
Nexqual rates Precision Optics Corporation, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 10:07 UTC.
| Growth | Strong — Revenue +108% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $11M cash vs $4M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$1M |
| Efficiency | Critical — ROE -30%, ROA -11.2% |
Ownership (POCI)
| Insider Ownership | +20.98% |
|---|---|
| Institutional Ownership | +43.73% |
| Shares Outstanding | 10.94M |
| Float | 8.12M |
| Short % of Float | +0.32% |
Source: Nexqual, June 10, 2026 at 10:07 UTC.
Leadership (POCI)
Precision Optics Corporation, Inc. is led by Joseph N. Forkey (age 57), CEO, President, Treasurer & Director, per Nexqual as of June 10, 2026 at 10:07 UTC.
| CEO, President, Treasurer & Director | Joseph N. Forkey (age 57) |
|---|---|
| CFO, Principal Accounting Officer & Secretary | Wayne M. Coll (age 61) |
| Founder, Advisor to the CEO & Director Emeritus | Richard E. Forkey (age 85) |
| Chief Operating Officer | Joseph Traut (age 53) |
| Vice President of Sales & Marketing | Clay Schwabe |
Major Backers & Investors (POCI)
Notable institutional backers of Precision Optics Corporation, Inc. include Needham Investment Management, L.L.C., Needham Funds Inc-Needham Aggressive Growth Fund, MYDA Advisors LLC, according to Nexqual as of June 10, 2026 at 10:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Needham Investment Management, L.L.C. | 29.63% |
| Needham Funds Inc-Needham Aggressive Growth Fund | 29.63% |
| MYDA Advisors LLC | 7.09% |
| Nantahala Capital Management, LLC | 4.97% |
| Bleichroeder LP | 4.81% |
| Wealthtrust Axiom, LLC | 4.51% |
| Archon Capital Management LLC | 2.78% |
| Morgan Stanley | 2.55% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 6.88% |
Source: Nexqual, June 10, 2026 at 10:07 UTC.
From Precision Optics Corporation, Inc.'s Latest SEC 10-K Filing (filed 2025-09-29)
Key Strengths & Strategy (as disclosed to the SEC)
- Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
- The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.
- It also provides components and assemblies for industrial and military use.
- It markets its products to medical device companies.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FBCE | FIBERCORE INC | USD 0 | ▲ 0% |
| NEWP | New Pacific Metals Corp. | USD 4.13 | ▼ 2.59% |
| OPTX | Syntec Optics Holdings, Inc. | USD 11.63 | ▲ 2.47% |
| ETEK | Eco-Tek Group, Inc. | USD 0 | ▲ 0% |
| PIII | P3 Health Partners Inc. | USD 12.54 | ▲ 8.29% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 10:07 UTC. This page is informational and not investment advice.